[{"arm_notes": "", "treatment_id": null, "treatment_name": "Randomized controlled tiral with 2 arms one intervention arm and the other is a placebo arm;Endothelial dysfunction will be targeted by our medications to improve patient outcome in COVID-19 infection;3g po TID;5 mg po OD;40 mg po OD;10 mg po BID;2.5-5 mg po OD;Endothelial dysfunction and COVID-19;Supplement;Supplement;medication;Medication;Medication", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2236, "treatment_name": "Atorvastatin+folic acid+l-arginine+nebivolol+nicorandil", "treatment_type": "Metabolic agents+vitamins and dietary supplements+cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]